Please provide your email address to receive an email when new articles are posted on . Exposure to fine particulate matter raised the risk for a diagnosis of pulmonary hypertension. Previous/current ...

There is increased risk for lung transplantation or death among patients with pulmonary arterial hypertension who have long-term exposure to particulate matter. Investigators explored the link between ...

Pulmonary arterial hypertension (PAH) is a rare, progressive, and often fatal cardiopulmonary condition characterized by pulmonary vascular remodeling and progressive narrowing, leading to increased ...

Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results ...

Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...

Frailty and accelerated aging are common in pulmonary hypertension, with frailty an independent risk factor for early death.

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

The phase 2 Cadence trial met its primary endpoint, showing that Winrevair improved the ability of blood to transition through the lungs to the heart in patients with combined post- and precapillary ...

Winrevair yielded significant and meaningful clinical benefits for patients with combined post- and precapillary pulmonary ...

Pulmonary thromboendarterectomy is a surgery used to treat chronic thromboembolic pulmonary hypertension. It’s the treatment of choice for this condition. Chronic thromboembolic pulmonary hypertension ...